BNET Industries
Last Fiscal Year Sales:$57.8M
- Public
- US
Dow Jones Description
We were incorporated in Delaware in March 1984. We are a holding company that operates through our subsidiaries, MTS Packaging Systems, Inc. (MTSP), MTS Medication Technologies, Ltd. (MTS Limited), BAF Printers, Ltd. (BAF) and MTS Medication Technologies GmbH (MTS GmbH). BAF and MTS GmbH are wholly owned subsidiaries of MTS Limited. MTS primarily manufactures and sells consumable medication punch cards, packaging equipment and ancillary products throughout the United States (the U.S.), Canada and Europe. Our customers are predominantly institutional pharmacies that supply nursing homes, assisted living and correctional facilities with prescription medications for their patients. MTS manufactures its proprietary consumable punch cards and most of our packaging equipment in our own facilities. This manufacturing process uses integrated equipment for manufacturing the consumable medication punch cards. In addition, we utilize the services of outside contract manufacturers for some of our packaging equipment. The consumable medication punch cards and packaging equipment are designed to provide a cost effective method for pharmacies to dispense medications. MTSs medication dispensing systems and products provide innovative methods for dispensing medications in disposable packages. MTS Limited distributes products for MTS primarily in the United Kingdom (the U.K.). BAF manufactures and sells prescription bags and labels in the U.K. MTS GmbH distributes products for MTS in Germany. ...
Chairman of The Board, President and Chief Executive OfficerTodd E. Siegel
Number of Employees 236
Contact Information
2003 Gandy Blvd.
Suite 800
St. Petersburg, Florida 33702
(800) 671-0508
NAICS Code Packaging Machinery Manufacturing: 333993
Recent Events
-
MTS Medication Tech. MTSI Tops Q4 Views
-
MTS Medication Technologies, Inc. Announces Third Quarter and Nine-Month Financial Results
News & Analysis
Filter by
mts medication technologies inc. - All News and Analysis
MTS Medication Technologies Switches to The NASDAQ Stock Market
ST. PETERSBURG, Fla. -- MTS Medication Technologies, Inc. ("MTS") (AMEX:MPP) announced today that its Board of Directors has approved the decision to switch the listing of its common stock from The American Stock Exchange to The NASDAQ Stock Market LLC[R]. On July 2, 2008, MTS provided The American Stock Exchange...
Speak with other shareholders about: (OTCBB: ZHNP), (AMEX: MPP), (AMEX:GRZ), and (AMEX: UQM) .
M2 PRESSWIRE-9 May 2007-Stockwire.com: Speak with other shareholders about: (OTCBB: ZHNP), (AMEX: MPP), (AMEX:GRZ), and (AMEX: UQM) .C1994-2007 M2 COMMUNICATIONS LTD RDATE:09052007 AUSTIN, TX: Have you ever watched a STOCKUMENTARY? Click the following link to view your first ever full length...
Additional Resources
MTS Reports Financial Results for 4Q and Fiscal Year
Wireless News06-19-2009MTS Reports Financial Results for 4Q and Fiscal YearType: NewsMTS Medication Technologies, Inc., an international provider of medication adherence packaging systems, announced its financial results for its fourth quarter and year ended March 31. The company reported in a June 16 release that revenue for the fourth quarter...
MTS Announces Financial Results for Fourth Quarter and Fiscal Year Ended March 31, 2009
Revenue up 32% - EPS up 19% for the Year Provides General Business Update ST. PETERSBURG, Fla. -- MTS...
MTS Medication Technologies to Host 4Q Conference Call
Wireless News06-12-2009MTS Medication Technologies to Host 4Q Conference CallType: NewsMTS Medication Technologies announced that it will release its fourth quarter and year-end results for the period ended March 31, before the market opens on Tuesday, June 16. Management of the company will host a conference call on that day...
MTS Medication Technologies Schedules 4Q and Year Ended March 31, Conference Call
Wireless News06-12-2009MTS Medication Technologies Schedules 4Q and Year Ended March 31, Conference CallType: NewsMTS Medication Technologies, Inc. announced that it will release its fourth quarter and year-end results for the period ended March 31, before the market opens on Tuesday, June 16. In a release, the company noted event...
MTS Medication Technologies to Host Fourth Quarter and Year Ended March 31, 2009 Conference Call on Tuesday, June 16, 2009
ST. PETERSBURG, Fla. -- MTS Medication Technologies, Inc. (Nasdaq:MTSI) ( www.mts-mt.com ) today announced that it will release its fourth quarter and year-end results for the period ended...
MTS Medication Technologies, Inc. Announces Third Quarter and Nine-Month Financial Results
Revenue And EPS Increase in the Third Quarter ST. PETERSBURG, Fla. -- MTS Medication Technologies, Inc. (NasdaqCM:MTSI), an international provider of medication adherence packaging systems, today announced its financial results for its third quarter and nine months ended December 31, 2008. Third Quarter Net...
MTS Medication Technologies Announces Postponement of Three- and Nine-Month Financial Results
ST. PETERSBURG, Fla. -- MTS Medication Technologies, Inc. (NasdaqCM:MTSI) (www.mts-mt.com) today announced that the release of its three- and nine-month financial results that was scheduled for Tuesday, February 10, 2009 has been postponed until before the market opens on Tuesday, February 17, 2009. Management of the Company will...
MTS Medication Technologies to Host Third Quarter and Nine Months Conference Call on Tuesday, February 10, 2009
ST. PETERSBURG, Fla. -- MTS Medication Technologies, Inc. (NasdaqCM:MTSI) (www.mts-mt.com) today announced that it will release its third quarter and nine-month results for the period ended December 31, 2008 before the market opens on Tuesday, February 10, 2009. Management of the Company will host a conference call on...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Michael Branca | CFO |
| Michael D. Stevenson | COO & Vice President, Finance |
| Michael P. Conroy | Vice President and Chief Financial Officer Exhibit Index |
| Joshua B. Sinsley | Vice President, Business Development |
| Perry W. Larson | Vice President, Sales and Marketing |
| Peter M. Benjamin | Vice President, HR |
| Peter T. Gilbert | Vice President, Marketing |
| Ron Rosenbaum | Vice President, Technology |
| Peter A. Williams | Managing Director, Subsidiary |
| Tammy Leon | Manager, HR |
| James M. Conroy | Controller |
| Terri Dunbar | Controller |
| Michael Conroy James | Principal Accounting Officer |
| Irv Cohen | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Todd E. Siegel | Chairman of The Board, President and Chief Executive Officer |
| Allen S. Braswell | Board of Directors |
| Chet Borgida | Board of Directors |
| David W. Kazarian | Board of Directors |
| Edgardo A. Mercadante | Board of Directors |
| Frank A. Newman | Board of Directors |
| John Stanton | Vice Chairman |
Todd E. Siegel. Mr. Siegel became our President and Chief Executive Officer in 1992 and has served as a director of MTS since 1986. Mr. Siegel served from 1988 to 1992 as Executive Vice President and Chief Operating Officer of MTS and from 1985 to 1988 as Vice President of Sales. Additionally, Mr. Siegel served as our Secretary from 1986 to 1996. See Certain Transactions and Employment Agreements. Mr. Siegel currently serves as the President of the Golda Meir/Kent Jewish Center, the Vice President of Finance of Temple B nai Israel and a director of Halo, Inc. and Applied Magnetics, LLC, both privately owned companies.
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Chairman of The Board, President and Chief Executive Officer | Current |
| MTS Medication Technologies | Director | Current |
| MTS Medication Technologies | Chief Operating Officer | Former |
| MTS Medication Technologies | Executive Vice President | Former |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | CFO | Current |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | COO & Vice President, Finance | Current |
Michael P. Conroy serves as our Chief Financial Officer and his son, James M. Conroy, serves as our Controller. Because of the family relationship among these members of our management, certain employer/employee matters may not be conducted on a fully arms-length basis as would be the case if the family relationship did not exist. However, independent directors unrelated to the Conroy family comprise our Compensation Committee and Audit Committee and we expect that compensation and other significant employer/employee issues, including performance evaluations and compensation reviews, will be conducted on a fully arms-length basis as would be the case if the family relationship did not exist.
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Vice President and Chief Financial Officer Exhibit Index | Current |
| MTS Medication Technologies | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Vice President, Business Development | Current |
Perry W. Larson. Mr. Larson has been our Vice President, Sales and Marketing since April 2005. From October 2004 to April 2005, he was our Director of Sales. From April 2003 to October 2004, Mr. Larson was the Director of Sales for Financial Resources of America. From August 1999 to April 2003, Mr. Larson was a LTC Specialist for Farmers Group, Inc.
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Vice President, Sales and Marketing | Current |
| Financial Resources | Director of Sales | Former |
| Farmers Group, Inc. | Ltc Specialist | Former |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Vice President, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Vice President, Technology | Current |
Peter A. Williams. Mr. Williams has been the Managing Director of MTS Medication Technologies, Ltd. ( MTS Limited ) since September 2003. Mr. Williams was a Consultant Pharmacist to MTS from 2000 to 2003.
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Managing Director, Subsidiary | Current |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Manager, HR | Current |
James M. Conroy. Mr. Conroy has served as our Controller since February 2008. From June 2006 to October 2007, Mr. Conroy served as Managing Partner of Conroy & Febo, CPAs, a Florida accounting firm. From June 2005 to June 2006, Mr. Conroy served as Manager of Corporate Accounting for Starwood Vacation Ownership, a vacation ownership company that acquires, develops and markets resort communities throughout the world. From April 2001 to June 2005, Mr. Conroy served as Director, Finance and Controller of Ultimate Franchise Systems, Inc., a franchisor of quick service and casual dining restaurants. Mr. Conroy received a B.S.B.A. degree in accounting from the University of Central Florida and is an active Certified Public Accountant in the State of Florida.
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Controller | Current |
| Starwood Vacation Ownership | Manager | Former |
| University of Central Florida | B.S.B.A. Degree In Accounting | Former |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Principal Accounting Officer | Current |
Allen S. Braswell. Mr. Braswell has served as a director of MTS since 2005. Since 2007, Mr. Braswell has been the President of Pico-Tesla Magnetic Therapies, LLC. Mr. Braswell has been a member of the Board of Directors of Suntron Corp. since 1998, and has served on its audit and governance committees and as chairman of a special committee representing minority stockholders in matters related to an earlier merger. Prior to 1998, he was President of Jabil Global Services, Vice President of EFTC Services, President/CEO of Circuit Test Inc. and an attorney in practice with Tanney, Ford, Donahey, Eno and Mills, P.A. Mr. Braswell attended the U.S. Military Academy (West Point) and graduated from the University of Florida with a bachelor s degree in finance. He received his J.D. degree from University of Florida School of Law.
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Board of Directors | Current |
Chet Borgida - Chet Borgida was elected to the Board of Directors in November 2003. He serves as a member of Warren's audit committee, which he chairs. Mr. Borgida has more than 30 years of domestic and international management experience in auditing and advising retail, distribution and media businesses. He was a partner at Grant Thornton LLP, Warren's independent auditors, from 1977 to 2001. While at Grant Thornton LLP Mr. Borgida had no involvement in the review or preparation of Warren's audited financial statements. From 2001 to 2003, Mr. Borgida was the Senior Vice-President and Chief Financial Officer of Cross Media Marketing Corporation. Recently, he has been serving as the Chief Operating Officer of the Naples Realty Group, Inc. Mr. Borgida is also a director and member of the audit committees of Brand Partners Group, Inc., and Correctional Services Corporation, both Nasdaq listed companies. He was graduated from Hunter College with a Bachelor Degree in Business Science in 1967. He is a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants.
| Organization | Position | Status |
|---|---|---|
| Warren Resources, Inc. | Chair | Current |
| Warren Resources, Inc. | Board of Directors | Current |
| MTS Medication Technologies | Board of Directors | Current |
| Grant Thornton LLP | partner | Former |
| Hunter College of the City University of New York | Bachelor Degree in Business Science | Former |
| BrandPartners Group | member | Former |
David W. Kazarian. Mr. Kazarian has served as a director of MTS since 1988. Mr. Kazarian also serves as a director of Delta RF Technology, Inc., a privately held corporation that manufactures computer components for an international customer base. Prior to its sale in December 1990, Mr. Kazarian and his wife owned and operated Kazarian Pharmacy. Since March 1991, Mr. Kazarian has been the founder and President of Infuserve America, Inc., a firm involved in the home health care business. He is also currently the president of the Kazarian Group Consultants which provides consulting services for certain surgical centers in Pinellas County, Florida and Nursing homes in Connecticut and Massachusetts. Mr. Kazarian received his bachelor s degree in pharmacy from the University of Florida s School of Pharmacy.
| Organization | Position | Status |
|---|---|---|
| Delta Rf Technology, Inc. | Director | Current |
| MTS Medication Technologies | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Drugmax Inc. | CEO | Current |
| Familymeds Group, Inc. | Chief Executive Officer | Current |
| Familymeds, Inc. | President, Chief Executive Officer, Chairman | Current |
| Familymeds Group, Inc. | Chairman | Current |
| Drugmax Inc. | Chairman | Current |
| Origin Biomed Inc | Board of Directors | Current |
| MTS Medication Technologies | Board of Directors | Current |
| Prohealth Physicians | Director | Current |
| General Nutrition Centers, Inc. | Board of Directors | Current |
| University of the Sciences | Board of Directors | Current |
| Familymeds Group, Inc. | President | Former |
| Rite Aid Corporation | Division Manager | Former |
| Drugmax Inc. | Director | Former |
| University of the Sciences in Philadelphia | B.S. degree in Pharmacy | Former |
| University Corp. | Former | |
| Prohealth Physicians | member | Former |
| Organization | Position | Status |
|---|---|---|
| MTS Medication Technologies | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Southeast Capital Ventures | Chief Executive Officer | Current |
| Southeast Capital Ventures | President | Current |
| Dhs Technologies | Chief Financial Officer | Current |
| Reeves Ems, LLC | Chief Financial Officer | Current |
| Persystent Technology Corporation | Current | |
| Association for Financial Professionals | Board of Directors | Current |
| Dhs Technologies | Board of Directors | Current |
| MTS Medication Technologies | Director | Current |
| Barclays | CEO | Former |
| Barclays | Cfo | Former |
| GunnAllen Financial Inc. | Executive Vice President | Former |
| ABN AMRO Holding N.V. | Managing Director | Former |
| ABN AMRO Incorporated | Managing Director | Former |
| Financial Professionals | Former | |
| Coopers & Lybrand, L.L.P. | Former | |
| Pace University | MBA | Former |
| New York University | Degree In Finance | Former |
| Organization | Position | Status |
|---|---|---|
| Nanobac Pharmaceuticals, Inc. | Co-Chairman, Chief Executive Officer and Chief Financial Officer | Former |
| National Sourcing, Inc | Chairman, CEO, President | Current |
| Cast Crete Corporation | Chairman | Current |
| Nanobac Pharmaceuticals, Inc. | Chief Executive and Financial Officer, and Chairman | Former |
| Medtech, Inc. | Board of Directors | Current |
| Powercerv Corp | Board of Directors | Current |
| Nanobac Pharmaceuticals, Inc. | Board of Directors | Current |
| Online Sales Strategies | Board of Directors | Current |
| Florida Engineered Construction Products Corp. | Chief Executive Officer | Former |
| Florida Engineered Construction Products Corp. | President | Former |
| EarthFirst Technologies Incorporated | Chairman, President & CEO | Former |
| National Sourcing, Inc | Founder | Former |
| Ernst & Young | Former | |
| MTS Medication Technologies | Director | Former |
| University of South Florida | Mba | Former |
| University of South Florida | Bachelors Degree in Marketing and Accounting | Former |
| US Energy Initiatives Corp | Chairman | Former |
| US Energy Initiatives Corp | Board of Directors | Former |
Executive News
-
MTS Medication Technologies posts profit gain, stops guidance
Industry Transcripts by Seeking Alpha
-
Lindsay Corporation F3Q09 (Qtr End 05/31/09) Earnings Call Transcript
on Jul 01, 2009about LNN
-
Nike F4Q09 (Qtr End 5/31/09) Earnings Call Transcript
on Jun 24, 2009about NKE
-
Commercial Metals Company F3Q09 (Qtr End 05/31/09) Earnings Call Transcript
on Jun 23, 2009about CMC
-
Steelcase Inc. F1Q10 (Qtr End 05/29/09) Earnings Call Transcript
on Jun 23, 2009about SCS
-
Actuant Corporation F3Q09 (Qtr End 5/31/09) Earnings Call Transcript
on Jun 17, 2009about ATU
Glass Door
IndustryTop Rated
- Was N.Y. Post's Carlucci the Reason for News America Marketing's Settlement With Floorgraphics? 60 votes
- News America Marketing Whistleblower: Clients Were Charged for Ads That Never Appeared 47 votes
- News America Marketing's Alleged Plans to Seize Safeway Account Outlined in Suit 44 votes
- Compete: Twitter Passes New York Times 40 votes
- News America Marketing Group Buys Floorgraphics Just Hours After Settling Spying Lawsuit 29 votes
